NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

NIOSH R21 WTC Asthma
NIOSH R21 WTC Asthma

NCT07222501

Active Not RecruitingN/A

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions: Asthma

Interventions: SaMBA, Asthma Education - WTC Related

Countries: United States

Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the primary outcomes (asthma control \[asthma control test, ACT\], medication use, inhaler technique) as well as on other secondary outcomes including measures of physical function, self-management behaviors, feasibility and fidelity at baseline, at intervention completion at 3 months, and for sustainability at 6 months. This project will prepare the team for all aspects of a subsequent larger efficacy trial of SaMBA-WTC.

Eligibility overview

Sex: ALL

Age: 21 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Age \>=21 years;
* English or Spanish speaking;
* World Trade Center-certified asthma;
* on asthma controller medications (as needed or standing);
* uncontrolled asthma.

Exclusion Criteria:

* Physician's diagnosis of dementia,
* COPD or other chronic pulmonary disease,
* \>15 pack-years history of smoking to avoid enrolling WTC responders with undiagnosed COPD.
Locations (1)
  • New York, New York, United States